ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
CLEC16A |
Q2KHT3
|
C-type lectin domain containing 16A
|
|
0.28 |
0.612 |
0.654 |
CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
CXCR3 |
P49682
|
C-X-C motif chemokine receptor 3
|
G-protein coupled receptor
|
0.18 |
0.436 |
0.808 |
FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
FCRL3 |
Q96P31
|
Fc receptor like 3
|
Cell adhesion
|
6.0E-21 |
0.612 |
0.769 |
FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
GATA3 |
P23771
|
GATA binding protein 3
|
|
0.90 |
0.415 |
0.846 |
HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
HLA-G |
P17693
|
major histocompatibility complex, class I, G
|
|
1.4E-11 |
0.461 |
0.769 |
HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IL13 |
P35225
|
interleukin 13
|
|
1.4E-02 |
0.386 |
0.846 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL18 |
Q14116
|
interleukin 18
|
|
3.1E-02 |
0.365 |
0.923 |
IL1A |
P01583
|
interleukin 1 alpha
|
|
1.6E-04 |
0.333 |
0.962 |
IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
IL1RN |
P18510
|
interleukin 1 receptor antagonist
|
|
3.1E-02 |
0.373 |
0.923 |
IL23R |
Q5VWK5
|
interleukin 23 receptor
|
Signaling
|
5.6E-04 |
0.466 |
0.769 |
IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |